What does CUSIP 14888U101 represent in this 13F holders report?

CUSIP 14888U101 is the security identifier for CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in Q2 2015?

86 institutional investors reported CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock for Q2 2015. Use the holders table for investor-level position and value details.

CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

CUSIP: 14888U101

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class: Equity / Common Stock
Shares outstanding: 123,180,519
Total 13F shares: 43,473,000
Share change: +4,567,541
Total reported value: $179,861,198
Put/Call ratio: 28%
Price per share: $4.13
Number of holders: 86
Value change: +$18,861,290
Number of buys: 60
Number of sells: 32

Quarterly Holders Quick Answers

What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2015
Previous quarter: Q1 2015

Recent filing periods for CUSIP 14888U101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAKER BROS. ADVISORS LP	13F	Company	6.1%	7,565,462	$32,758,000	—	31 Mar 2015	13F
Point72 Asset Management, L.P.	13F	Company	5.3%	6,568,000	$28,439,000	—	31 Mar 2015	13F
Consonance Capital Management LP	13F	Company	3.9%	4,849,870	$21,000,000	—	31 Mar 2015	13F
Broadfin Capital, LLC	13F	Company	3.3%	4,083,177	$17,680,000	—	31 Mar 2015	13F
FRANKLIN RESOURCES INC	13F	Company	2%	2,511,600	$10,875,000	—	31 Mar 2015	13F
VANGUARD GROUP INC	13F	Company	1.8%	2,228,589	$9,650,000	—	31 Mar 2015	13F
FEDERATED HERMES, INC.	13F	Company	1.6%	1,985,000	$8,595,000	—	31 Mar 2015	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.97%	1,200,000	$5,196,000	—	31 Mar 2015	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.89%	1,100,000	$4,763,000	—	31 Mar 2015	13F
Catalyst Capital Advisors LLC	13F	Company	0.87%	1,075,000	$4,655,000	—	31 Mar 2015	13F
MORGAN STANLEY	13F	Company	0.63%	770,731	$3,338,000	—	31 Mar 2015	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.3%	365,000	$1,580,000	—	31 Mar 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.29%	352,848	$1,527,000	—	31 Mar 2015	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.28%	344,754	$1,493,000	—	31 Mar 2015	13F
Allianz Asset Management GmbH	13F	Company	0.25%	313,523	$1,358,000	—	31 Mar 2015	13F
DEUTSCHE BANK AG\	13F	Company	0.2%	242,493	$1,049,000	—	31 Mar 2015	13F
Informed Momentum Co LLC	13F	Company	0.19%	232,176	$1,005,000	—	31 Mar 2015	13F
RUSSELL FRANK CO/	13F	Company	0.16%	201,802	$874,000	—	31 Mar 2015	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.15%	184,782	$800,000	—	31 Mar 2015	13F
BlackRock Fund Advisors	13F	Company	0.15%	184,773	$800,000	—	31 Mar 2015	13F
CREDIT SUISSE AG/	13F	Company	0.13%	160,169	$693,000	—	31 Mar 2015	13F
TFS CAPITAL LLC	13F	Company	0.13%	157,195	$681,000	—	31 Mar 2015	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.12%	151,110	$654,000	—	31 Mar 2015	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.12%	148,000	$641,000	—	31 Mar 2015	13F
Employees Retirement System of Texas	13F	Company	0.11%	138,000	$598,000	—	31 Mar 2015	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.1%	124,399	$539,000	—	31 Mar 2015	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.12%	150,000	$533,000	—	31 Mar 2015	13F
BlueCrest Capital Management Ltd	13F	Company	0.1%	119,054	$516,000	—	31 Mar 2015	13F
CORRADO ADVISORS, LLC	13F	Company	0.09%	105,700	$458,000	—	31 Mar 2015	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.08%	102,924	$446,000	—	31 Mar 2015	13F
TANAKA CAPITAL MANAGEMENT INC	13F	Company	0.09%	111,693	$438,000	—	31 Mar 2015	13F
NORTHERN TRUST CORP	13F	Company	0.08%	96,424	$418,000	—	31 Mar 2015	13F
Bank of New York Mellon Corp	13F	Company	0.07%	92,201	$399,000	—	31 Mar 2015	13F
A.R.T. Advisors, LLC	13F	Company	0.07%	92,100	$398,000	—	31 Mar 2015	13F
WHALEROCK POINT PARTNERS, LLC	13F	Company	0.07%	84,900	$367,000	—	31 Mar 2015	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.07%	82,372	$357,000	—	31 Mar 2015	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.05%	64,259	$278,000	—	31 Mar 2015	13F
PIPER SANDLER & CO.	13F	Company	0.04%	50,000	$217,000	—	31 Mar 2015	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.04%	46,438	$201,000	—	31 Mar 2015	13F
STATE STREET CORP	13F	Company	0.04%	44,400	$193,000	—	31 Mar 2015	13F
Cowen Prime Services LLC	13F	Company	0.03%	43,025	$186,000	—	31 Mar 2015	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.03%	37,875	$164,000	—	31 Mar 2015	13F
CITADEL ADVISORS LLC	13F	Company	0.03%	35,298	$153,000	—	31 Mar 2015	13F
STIFEL FINANCIAL CORP	13F	Company	0.03%	35,000	$152,000	—	31 Mar 2015	13F
AGRAN LIBBIE	13F	Company	0.03%	34,000	$147,000	—	31 Mar 2015	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.03%	41,332	$138,000	—	31 Mar 2015	13F
Financial Architects, Inc	13F	Company	0.02%	30,000	$130,000	—	31 Mar 2015	13F
Verition Fund Management LLC	13F	Company	0.02%	23,050	$100,000	—	31 Mar 2015	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.02%	21,227	$92,000	—	31 Mar 2015	13F
CTC Alternative Strategies, Ltd.	13F	Company	0.01%	18,000	$77,940	—	31 Mar 2015	13F

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q2 2015

As of 30 Jun 2015, CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by 86 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,473,000 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, Consonance Capital Management LP, FEDERATED INVESTORS INC /PA/, Broadfin Capital, LLC, Point72 Asset Management, L.P., FRANKLIN RESOURCES INC, VANGUARD GROUP INC, BlackRock Fund Advisors, Catalyst Capital Advisors LLC, and SPHERA FUNDS MANAGEMENT LTD.. This page lists 86 institutional shareholders reporting positions in this security for the Q2 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2015 vs Q1 2015 Across Filers

Q1 2015 holders

Q2 2015 holders

Holder diff

Investor	Q1 2015 Shares	Q2 2015 Shares	Share Diff	Share Chg %	Q1 2015 Value $	Q2 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.